Company Filing History:
Years Active: 2019
Title: Michael Daniel Goldsmith: Innovator in Sodium Channel Inhibition
Introduction
Michael Daniel Goldsmith is a notable inventor based in Saffron Walden, Essex, GB. He has made significant contributions to the field of pharmacology, particularly in the development of sodium channel inhibitors. His work focuses on innovative compounds that have the potential to treat various diseases.
Latest Patents
Goldsmith holds a patent for "Amino-substituted heterocyclic derivatives as sodium channel inhibitors." This invention relates to novel aminoindazolyl derivative compounds, which are designed to modulate voltage-gated sodium channels, specifically Nav1.7. The compounds have promising applications in treating diseases that are mediated by these channels.
Career Highlights
Goldsmith is currently associated with Almirall, S.A., a company known for its commitment to developing innovative pharmaceutical solutions. His role at Almirall allows him to contribute to cutting-edge research and development in the field of medicine.
Collaborations
Throughout his career, Goldsmith has collaborated with talented professionals, including James Duffy and Mark Stuart Chambers. These collaborations have likely enhanced the scope and impact of his research.
Conclusion
Michael Daniel Goldsmith is a distinguished inventor whose work in sodium channel inhibition holds great promise for medical advancements. His contributions to the field exemplify the importance of innovation in addressing complex health challenges.